Bradykinin dilates rat middle cerebral artery and its large branches via endothelial B2 receptors and release of nitric oxide

Ring segments of rat middle cerebral artery (MCA) were prepared for measurement of isometric force and precontracted with 10^?4 M uridine triphosphate (UTP). Concentration-effect curves (CEC) were constructed for bradykinin (BK, 10^?8–10^?5 M) in segments with functionally intect (E+) or denuded (E?) endothelium. E? segments did not dilate to BK. The BK receptor was characterized by application of specific B₁ or B₂ antagonists des-Arg⁹-Leu⁸] BK (10^?5 M) and -Arg⁰-Hyp³-Thi⁵- -Tic⁷-Oic⁸] BK (HOE140,3 × 10^?7 M), respectively, or B₁ agonist des-Arg⁹] BK (10^?8–10^?4 M). Involvement of nitric oxide (NO) was tested with N^G-nitro- -arginine (LNNA, 10^?4 M). BK induced concentration-dependent relaxation with a maximal effect (E_max) of 40.86 ± 1.50% at 10^?6 M and a pD₂ (?log₁₀ EC₅₀) of 6.818 ± 0.044. This relaxation could be prevented with HOE140 or LNNA, but was not influenced by des-Arg⁹-Leu⁸] BK. des-Arg⁹] BK did not induce any effect. These results demonstrate that BK induced relaxation via endothelial B₂ receptors and release of NO in isolated rat MCA.